Platelet-activating factor in Japanese cedar pollinosis.
Tatsuro Nakamura, K Ishihara, M Kuriyama, Ito K, Y Matsumura
Abstract
Tatsuro Nakamura, K Ishihara, M Kuriyama, Ito K, Y Matsumura
Abstract
The concentration of lyso-PAF in serum from untreated patients with Japanese cedar pollinosis, a typical allergic disease, was significantly higher than that in healthy controls. It was also found that the lyso-PAF level in serum from Japanese cedar pollinosis significantly decreased after therapy with ketotifen, an anti-allergic drug. These results suggest that PAF might play an important role in Japanese cedar pollinosis and that the clinical effect of anti-allergic drug might be partially due to the anti-PAF action.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The concentration of lyso-PAF in serum from untreated patients with Japanese cedar pollinosis, a typical allergic disease, was significantly higher than that in healthy controls. It was also found that the lyso-PAF level in serum from Japanese cedar pollinosis significantly decreased after therapy with ketotifen, an anti-allergic drug. These results suggest that PAF might play an important role in Japanese cedar pollinosis and that the clinical effect of anti-allergic drug might be partially due to the anti-PAF action.
Key concepts: Ketotifen, Platelet-activating factor, Medicine, Immunology, Drug, Pharmacology, Asthma